Community-acquired pneumonia: etiologic changes in a limited geographic area. An 11 year prospective study

I. Suarez, R. Fernandez, G. Rubinos, A. Torres, J. A. Gullon, A. Medina, A. Jimenez, H. Gonzalez, R. Galindo, I. Gonzalez (La Laguna. Santa Cruz de Tenerife, Spain)

Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia
Session: Antibiotic treatment in community-acquired pneumonia
Session type: Electronic Poster Discussion
Number: 1888
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Suarez, R. Fernandez, G. Rubinos, A. Torres, J. A. Gullon, A. Medina, A. Jimenez, H. Gonzalez, R. Galindo, I. Gonzalez (La Laguna. Santa Cruz de Tenerife, Spain). Community-acquired pneumonia: etiologic changes in a limited geographic area. An 11 year prospective study. Eur Respir J 2007; 30: Suppl. 51, 1888

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Community-acquired pneumonia in the elderly: Spanish multicentre study
Source: Eur Respir J 2003; 21: 294-302
Year: 2003



The presence of diabetes does not influence clinical outcomes in patients with community-acquired pneumonia: results from the community-acquired pneumonia organization (CAPO) international cohort study
Source: Annual Congress 2007 - Severity scores and comorbidities in community-acquired pneumonia
Year: 2007


New evidence of risk factors for community-acquired pneumonia: a population-based study
Source: Eur Respir J 2008; 31: 1274-1284
Year: 2008



Do not resuscitat orders in community-acquired pneumonia: a restrospective cohort study.
Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers
Year: 2017

Mortality directly related to community-acquired pneumonia (CAP) in hospitalized patients: results from the community-acquired pneumonia organization (CAPO) international cohort study
Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia
Year: 2007


Community-acquired pneumonia in the elderly: Spanish multicentre study
Source: Eur Respir J 2001; 18: Suppl. 33, 189s
Year: 2001

Community-acquired pneumonia. Prospective inpatient study
Source: Eur Respir J 2004; 24: Suppl. 48, 414s
Year: 2004

The extent of microbiological testing and antibiotic de-escalation in adults with community-acquired pneumonia: a retrospective cohort study.
Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection
Year: 2018

Etiology of community-acquired pneumonia requiring hospitalization in Chile: a prospective study
Source: Eur Respir J 2005; 26: Suppl. 49, 255s
Year: 2005

Significant decrease in long-term survival for hospitalised patients with community-acquired pneumonia (CAP): results from the community-acquired pneumonia organisation (CAPO) international cohort study
Source: Annual Congress 2009 - Impact of biomarkers in the management of community-acquired pneumonia
Year: 2009


Community-acquired pneumonia trough enterobacteriaceae and p. aeruginosa: diagnosis, incidence, and predictors. The German CAPNETZ
Source: Annual Congress 2009 - Respiratory infection caused by Pseudomonas aeruginosa
Year: 2009

Community-acquired pneumonia (CAP) in patients admitted to a central hospital: an 18 months retrospective study
Source: Eur Respir J 2003; 22: Suppl. 45, 150s
Year: 2003

Female gender is associated with poor clinical outcomes in hospitalized patients with community-acquired pneumonia: results from the CAPO international cohort study
Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Year: 2008


The impact of hyperglycemia on community-acquired pneumonia: A retrospective cohort study
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016


Community-acquired pneumonia in COVID-19 positive children: monitoring the clinical course
Source: Virtual Congress 2021 – Acute paediatric respiratory infections
Year: 2021


Risk factors (RF) for community-acquired pneumonia (CAP) in adults. A population-based case-control study
Source: Eur Respir J 2002; 20: Suppl. 38, 419s
Year: 2002

Outcome of community-acquired pneumonia: influence of age, residence status and antimicrobial treatment
Source: Eur Respir J 2008; 32: 139-146
Year: 2008



Epidemiology and outcomes in hospitalized patients with health-care-associated pneumonia (HCAP) and community-acquired pneummonia (CAP)~ A prospective observational cohort analysis
Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia
Year: 2009

Prospective comparative study on etiologic diagnosis of ventilator-associated pneumonia.
Source: International Congress 2018 – Epidemiology and prognostication of critically-ill patients
Year: 2018




Microbiological study of community acquired pneumonia versus nosocomial pneumonia in pediatric age group
Source: Eur Respir J 2004; 24: Suppl. 48, 714s
Year: 2004